{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:50:24Z","timestamp":1787064624202,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.contraception.2012.09.001","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T15:01:36Z","timestamp":1349190096000},"page":"622-630","source":"Crossref","is-referenced-by-count":40,"title":["First-trimester abortion in women with medical conditions"],"prefix":"10.1016","volume":"86","author":[{"given":"M.","family":"Guiahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.contraception.2012.09.001_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1363\/4304111","article-title":"Abortion incidence and access to services in the United States, 2008","volume":"43","author":"Jones","year":"2011","journal-title":"Perspect Sex Reprod Health"},{"issue":"2 Pt 1","key":"10.1016\/j.contraception.2012.09.001_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/AOG.0b013e31823fe923","article-title":"The comparative safety of legal induced abortion and childbirth in the United States","volume":"119","author":"Raymond","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2012.09.001_bb0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.AOG.0000116260.81570.60","article-title":"Risk factors for legal induced abortion-related mortality in the United States","volume":"103","author":"Bartlett","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2012.09.001_bb0020","first-page":"1","article-title":"Abortion surveillance \u2014 United States, 2007","volume":"60","author":"Pazol","year":"2011","journal-title":"MMWR Surveill Summ."},{"issue":"6","key":"10.1016\/j.contraception.2012.09.001_bb0025","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/AOG.0b013e3181fdfb11","article-title":"Pregnancy-related mortality in the United States, 1998 to 2005","volume":"116","author":"Berg","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"RR-4","key":"10.1016\/j.contraception.2012.09.001_bb0030","first-page":"1","article-title":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2010","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1016\/j.contraception.2012.09.001_bb0035","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1586\/erc.09.152","article-title":"Cardiac drug use in pregnancy: safety, effectiveness and obstetric implications","volume":"7","author":"Newstead-Angel","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"10.1016\/j.contraception.2012.09.001_bb0040","first-page":"1","article-title":"Pregnancy-related mortality surveillance \u2014 United States, 1991 \u2014 1999","volume":"52","author":"Chang","year":"2003","journal-title":"MMWR Surveill Summ."},{"issue":"3","key":"10.1016\/j.contraception.2012.09.001_bb0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1363\/3711005","article-title":"Reasons U.S. women have abortions: quantitative and qualitative perspectives","volume":"37","author":"Finer","year":"2005","journal-title":"Perspect Sex Reprod Health"},{"issue":"1","key":"10.1016\/j.contraception.2012.09.001_bb0050","first-page":"44","article-title":"Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling","volume":"26","author":"Einarson","year":"2001","journal-title":"J Psychiatry Neurosci"},{"issue":"8","key":"10.1016\/j.contraception.2012.09.001_bb0055","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1528-1157.2002.38601.x","article-title":"Self-discontinuation of antiepileptic medication in pregnancy: detection by hair analysis","volume":"43","author":"Williams","year":"2002","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.contraception.2012.09.001_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2006.03.003","article-title":"Mifepristone and prostaglandin for termination of pregnancy: contraindications for use, reasons and rationale","volume":"74","author":"Davey","year":"2006","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2012.09.001_bb0065","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1067\/mob.2000.108886","article-title":"Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy","volume":"183","author":"Ramsey","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.contraception.2012.09.001_bb0070","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/01443610802463686","article-title":"First and second trimester induced abortions in women with cardiac disorders: a 12-year analysis from a developing country","volume":"28","author":"Bagga","year":"2008","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.contraception.2012.09.001_bb0075","doi-asserted-by":"crossref","first-page":"212e211","DOI":"10.1016\/j.fertnstert.2006.11.010","article-title":"Medical management of early pregnancy failure in a patient with coronary artery disease","volume":"88","author":"Hackney","year":"2007","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.contraception.2012.09.001_bb0080","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2169\/internalmedicine.37.841","article-title":"Effect of prostaglandin E1 on cerebral blood flow in patients with chronic cerebral infarction","volume":"37","author":"Komaba","year":"1998","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.contraception.2012.09.001_bb0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neulet.2008.04.054","article-title":"Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia","volume":"438","author":"Li","year":"2008","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.contraception.2012.09.001_bb0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clineuro.2008.02.018","article-title":"Cryptogenic stroke in the setting of intravaginal prostaglandin therapy for elective abortion","volume":"110","author":"Patel","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.contraception.2012.09.001_bb0095","series-title":"Management of unintended and abnormal pregnancy: Comprehensive abortion care","first-page":"78","article-title":"Medical evaluation and management","author":"Davis","year":"2009"},{"issue":"3","key":"10.1016\/j.contraception.2012.09.001_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0020-7292(94)90252-6","article-title":"A time and cost analysis of the management of incomplete abortion with manual vacuum aspiration","volume":"45","author":"Blumenthal","year":"1994","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1016\/j.contraception.2012.09.001_bb0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.contraception.2006.04.010","article-title":"Timing of steps and reasons for delays in obtaining abortions in the United States","volume":"74","author":"Finer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.001_bb0110","unstructured":"Tsutsumi Y, Mizuno J, Takada S, Morita S. [Paracervical block for dilatation and curettage in a parturient with Eisenmenger's syndrome]. Masui. 59(3):379\u2013382. [Evidence Grade: III]"},{"key":"10.1016\/j.contraception.2012.09.001_bb0115","doi-asserted-by":"crossref","unstructured":"Sitruk-Ware, R. Mifepristone and misoprostol sequential regimen side effects, complications and safety. Contraception. 2006. 74(1): p. 48\u201355. 24. [Evidence Grade: III]","DOI":"10.1016\/j.contraception.2006.03.016"},{"issue":"1","key":"10.1016\/j.contraception.2012.09.001_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0029-7844(01)01375-8","article-title":"Curettage after mifepristone-induced abortion: frequency, timing, and indications","volume":"98","author":"Allen","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.contraception.2012.09.001_bb0125","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1432-1033.1994.00651.x","article-title":"Effects of mifepristone (RU-486) on heme metabolism and cytochromes P-450 in cultured chick embryo liver cells, possible implications for acute porphyria","volume":"225","author":"Cable","year":"1994","journal-title":"Eur J Biochem"},{"issue":"6","key":"10.1016\/j.contraception.2012.09.001_bb0130","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1345\/aph.10397","article-title":"Mifepristone","volume":"35","author":"DeHart","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.contraception.2012.09.001_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14656566.2.3.409","article-title":"The pharmacology of methotrexate","volume":"2","author":"Barnhart","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.contraception.2012.09.001_bb0140","unstructured":"Methylergonovine: drug information, UpToDate."},{"issue":"6","key":"10.1016\/j.contraception.2012.09.001_bb0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0010-7824(01)00279-7","article-title":"First trimester surgical abortion practices: a survey of National Abortion Federation members","volume":"64","author":"Lichtenberg","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.001_bb0150","unstructured":"Carboprost tromethamine: Drug information, in UpToDate."},{"key":"10.1016\/j.contraception.2012.09.001_bb0155","unstructured":"Solomon, D., Nonselective NSAIDs: Overview of adverse effects, UpToDate."},{"issue":"7","key":"10.1016\/j.contraception.2012.09.001_bb0160","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/diacare.24.7.1130","article-title":"Declining insulin requirement in the late first trimester of diabetic pregnancy","volume":"24","author":"Jovanovic","year":"2001","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.contraception.2012.09.001_bb0165","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/AOG.0b013e31816c9079","article-title":"Preoperative evaluation of the gynecologic patient: considerations for improved outcomes","volume":"111","author":"Johnson","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2012.09.001_bb0170","first-page":"40","article-title":"Black-white differences in age trajectories of hypertension prevalence among adult women and men, 1999\u20132002","volume":"17","author":"Geronimus","year":"2007","journal-title":"Ethn Dis"},{"issue":"1","key":"10.1016\/j.contraception.2012.09.001_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2005.04.002","article-title":"Family planning for obese women: challenges and opportunities","volume":"72","author":"Grimes","year":"2005","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2012.09.001_bb0180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1068-607X(98)00144-9","article-title":"Intraoperative blood loss and gestational age at pregnancy termination","volume":"5","author":"Marchiano","year":"1998","journal-title":"Prim Care Update Ob Gyns."},{"issue":"5","key":"10.1016\/j.contraception.2012.09.001_bb0185","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.ajog.2008.10.016","article-title":"Relationship of obesity to outcome of medical abortion","volume":"200","author":"Strafford","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.contraception.2012.09.001_bb0190","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.contraception.2009.08.001","article-title":"Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091","volume":"80","author":"Higginbotham","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2012.09.001_bb0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00002030-200401230-00018","article-title":"Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV","volume":"18","author":"Massad","year":"2004","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.contraception.2012.09.001_bb0200","doi-asserted-by":"crossref","first-page":"541e541","DOI":"10.1016\/j.ajog.2007.01.005","article-title":"Live birth patterns among human immunodeficiency virus-infected women before and after the availability of highly active antiretroviral therapy","volume":"196","author":"Sharma","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.contraception.2012.09.001_bb0205","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/jwh.2006.0204","article-title":"Contraceptive use among U.S. women with HIV","volume":"16","author":"Massad","year":"2007","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"10.1016\/j.contraception.2012.09.001_bb0210","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ajog.2004.05.045","article-title":"Morbidity that is associated with curettage for the management of spontaneous and induced abortion in women who are infected with HIV","volume":"191","author":"Stuart","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2012.09.001_bb0215","first-page":"469","article-title":"Management of status epilepticus","volume":"68","author":"Sirven","year":"2003","journal-title":"Am Fam Physician"},{"issue":"5","key":"10.1016\/j.contraception.2012.09.001_bb0220","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ajog.2003.09.057","article-title":"Effect of pregnancy and stage of pregnancy on asthma severity: a systematic review","volume":"190","author":"Kwon","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.contraception.2012.09.001_bb0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0889-8529(03)00008-2","article-title":"Perioperative management of patients treated with glucocorticoids","volume":"32","author":"Axelrod","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.contraception.2012.09.001_bb0230","first-page":"1","article-title":"Asthma prevalence, health care use, and mortality: United States, 2005\u20132009","volume":"32","author":"Akinbami","year":"2012","journal-title":"Natl Health Stat Report."},{"issue":"4","key":"10.1016\/j.contraception.2012.09.001_bb0235","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijoa.2006.12.004","article-title":"Total intravenous anesthesia for evacuation of a hydatidiform mole and termination of pregnancy in a patient with thyrotoxicosis","volume":"16","author":"Erturk","year":"2007","journal-title":"Int J Obstet Anesth"},{"issue":"2","key":"10.1016\/j.contraception.2012.09.001_bb0240","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1538-7836.2005.01150.x","article-title":"von Willebrand disease and pregnancy","volume":"3","author":"Kujovich","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.contraception.2012.09.001_bb0245","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.hoc.2011.01.006","article-title":"Von Willebrand disease in pregnancy","volume":"25","author":"Lipe","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"10.1016\/j.contraception.2012.09.001_bb0250","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/AOG.0b013e3181b191ea","article-title":"Von Willebrand disease: key points from the 2008 National Heart, Lung, and Blood Institute guidelines","volume":"114","author":"James","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2012.09.001_bb0255","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ogc.2006.05.003","article-title":"Thrombophilia and women's health: an overview","volume":"33","author":"Blickstein","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"5","key":"10.1016\/j.contraception.2012.09.001_bb0260","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.contraception.2010.09.009","article-title":"Blood loss at the time of first-trimester surgical abortion in anticoagulated women","volume":"83","author":"Kaneshiro","year":"2011","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2012.09.001_bb0265","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2796.2005.01477.x","article-title":"Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis","volume":"257","author":"Burger","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.contraception.2012.09.001_bb0270","first-page":"CD005158","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease","volume":"3","author":"Squizzato","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.contraception.2012.09.001_bb0275","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.contraception.2010.11.006","article-title":"Prevention of infection after induced abortion: release date October 2010: SFP guideline 20102","volume":"83","author":"Achilles","year":"2011","journal-title":"Contraception"},{"issue":"15","key":"10.1016\/j.contraception.2012.09.001_bb0280","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412008116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412008116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T06:56:19Z","timestamp":1562223379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412008116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0010782412008116"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.09.001","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}